Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

EBV and human cancer

Ko YH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders

Cai Q, Chen K, Young KH

Epstein-Barr virus, a ubiquitous human herpesvirus, can induce both lytic and latent infections that result in a variety of human diseases, including lymphoproliferative disorders. The oncogenic potential of Epstein-Barr virus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Modeling EBV infection and pathogenesis in new-generation humanized mice

Fujiwara S, Imadome KI, Takei M

The development of highly immunodeficient mouse strains has allowed the reconstitution of functional human immune system components in mice. New-generation humanized mice generated in this manner have been extensively used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

Ok CY, Li L, Young KH

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting >90% of the adult population. EBV targets B-lymphocytes and achieves latent infection in a circular episomal form. Different latency patterns are recognized...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epstein-Barr virus latent genes

Kang MS, Kieff E

Latent Epstein-Barr virus (EBV) infection has a substantial role in causing many human disorders. The persistence of these viral genomes in all malignant cells, yet with the expression of limited...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target

Tse E, Kwong YL

Epstein Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) express all EBV latent antigens (type III latency) in immunodeficient patients and limited antigens (type I and II latencies) in immunocompetent patients. Post-transplantation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma

Gulley ML

A small set of gastric adenocarcinomas (9%) harbor Epstein-Barr virus (EBV) DNA within malignant cells, and the virus is not an innocent bystander but rather is intimately linked to pathogenesis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr